Press Release: Innovex Announces First Quarter 2025 Results

Dow Jones
07 May

Innovex Announces First Quarter 2025 Results

HOUSTON--(BUSINESS WIRE)--May 06, 2025-- 

Innovex International, Inc. (NYSE: INVX) ("Innovex," the "Company" or "we") today announced financial and operating results for the first quarter of 2025.

First Quarter Highlights

   -- Revenue of $240 million, down 4% quarter over quarter 
 
   -- Net Income of $15 million, net income margin of 6% 
 
   -- Adjusted EBITDA1 of $46 million and Adjusted EBITDA Margin1 of 19% 
 
   -- Net Cash Provided by Operating Activities of $31 million 
 
   -- Free Cash Flow1 of $24 million 
 
   -- Income from Operations of $22 million 
 
   -- Return on Capital Employed1 of 12% 
 
   -- Closed on acquisition of SCF Machining Corporation ("SCF") 
 
   -- Completed first successful installation of VXTeTM Self-Orientating 
      Vertical Tree 

Key Subsequent Events

   -- Entered into a definitive agreement to sell the legacy Dril-Quip Eldridge 
      facility for $95 million. 
 
   -- As of May 5, 2025, we have repurchased 395,234 shares of Innovex common 
      stock at an average price of $14.94 per share 
 
(1)    Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and Return on 
       Capital Employed ("ROCE") are non-GAAP measures. Reconciliations of 
       Adjusted EBITDA to net income, Free Cash Flow to net cash provided by 
       operating activities and ROCE to income from operations, the most 
       directly comparable financial measures presented in accordance with 
       GAAP, are outlined in the reconciliation tables accompanying this 
       release. 
 

Adam Anderson, CEO commented, "We made substantial progress toward our vision to transform the legacy Dril-Quip business in the first quarter. The expected sale of the Eldridge facility will free up $95 million of capital and be a key enabler of the next step-change in margins and operational performance for the subsea business. The DWS business, our recent acquisition in Q4 2024, continued to gain market share in the quarter, driving revenue growth in the North American Land market. Although activity declined more than anticipated in Mexico during the first quarter, the team did an excellent job of responding to changing market conditions. We founded Innovex with the belief that cycles are a feature, not a bug of the business model. We have a well-worn playbook for industry cycles, and are ready to take advantage of volatility, should it persist."

Kendal Reed, CFO continued, "Our net-cash balance sheet, soon to be bolstered by the sale of the Eldridge facility, allows us to take advantage of accretive M&A and our recently announced share buyback program. Despite activity being lower than anticipated, we were able to maintain margins, highlighting the resilience of our capital-light business model. Importantly, we converted approximately 52% of our Adjusted EBITDA into Free Cash Flow, which further strengthened the balance sheet."

 
 Financial Summary 
 ----------------- 
 (in thousands) 
 
                                 Three Months Ended 
                    -------------------------------------------- 
                     March 31,      December 31,     March 31, 
                        2025            2024            2024 
                    ------------  ----------------  ------------ 
 Revenue            $240,415       $   250,687      $127,997 
 Net Income         $ 14,757       $    31,789      $ 16,417 
 Net Income Margin         6%               13%           13% 
 Adjusted EBITDA 
  (1)               $ 45,921       $    49,063      $ 32,505 
 Adjusted EBITDA 
  Margin (1)              19%               20%           25% 
 Net cash provided 
  by operating 
  activities        $ 31,090       $    36,345      $ 12,605 
 Free Cash Flow 
  (1)               $ 24,034       $    28,718      $ 10,183 
 Income from 
  operations        $ 21,850       $    26,912      $ 22,311 
 
 
                                Twelve Months Ended 
                    -------------------------------------------- 
                     March 31,      December 31,     March 31, 
                        2025            2024            2024 
                    ------------  ----------------  ------------ 
 ROCE (1)                 12%               12%           20% 
 
 
 
  (1)  Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and Return on 
       Capital Employed ("ROCE") are non-GAAP financial measures. See 
       definition of these measures and the reconciliation of GAAP to non-GAAP 
       financial measures in the Supplemental Information tables below. 
 

Operational & Financial Results

Kendal Reed, CFO commented, "Softness in the Mexico market resulted in weaker revenues than originally anticipated. The NAM Land business grew 17% sequentially despite the US rig count staying relatively flat. This was due primarily to the inclusion of a full quarter of the DWS acquisition--which exemplifies the type of inorganic growth we pursue: high margin, high returns, and highly accretive. We continue to see an active M&A pipeline of companies that similarly fit our qualitative and quantitative requirements--including returns on capital of 20% or greater. Aside from M&A, we now also have a competing use of capital through our recently authorized $100 million share repurchase program. As of May 5, 2025, we have repurchased approximately 395,234 shares at an average price of $14.94."

Adam Anderson, CEO concluded, "We remain focused on identifying new synergies and new market opportunities to support organic growth. Our flexible supply chain model and "small ticket, big impact" product proposition gives us the adaptability and margin resilience to navigate a wide range of macro environments. We don't claim to predict commodity prices or activity levels with precision--but we work hard to stay closely aligned with our customers' evolving needs. Downcycles are an inherent part of our business; we use them to our advantage to create value for our shareholders--particularly during periods of uncertainty or low activity."

Balance Sheet, Debt, Cash Flow & Other

Net cash provided by operating activities was $31 million and capital expenditures were $7 million (approximately 3% of revenue) for the first quarter of 2025.

Innovex generated free cash flow of $24 million during the first quarter of 2025 and ended the quarter with $68 million of cash and cash equivalents and $25 million of total debt. Innovex's net cash balance was $43 million dollars at the end of the quarter, with $103 million of availability under its revolving credit facility.

Innovex maintains conservative levels of leverage and ample liquidity to maximize strategic flexibility and to capitalize on M&A opportunities that meet our stringent quantitative and qualitative characteristics.

Return on Capital Employed ("ROCE")

Innovex's efficient capital allocation and capital-light business model enable the Company to generate strong returns on our invested capital. Income from operations for the twelve months ended March 31, 2025 was $49 million. Return on Capital Employed ("ROCE") for the twelve months ended March 31, 2025 was 12%. We remain focused on capital efficiency, which we believe is a key driver of sustainable value creation for our stockholders.

Q2 2025 Guidance

Looking to the second quarter of 2025, Innovex expects to generate $225 - $235 million in total revenue, assuming continued softness in Mexico and slight activity declines in the NAM land market. Innovex expects to generate Adjusted EBITDA of $40 - $45 million in the second quarter of 2025.

Conference Call Details

Management will host a conference call and a webcast to discuss the financial results on May 7, 2025, at 10:00 a.m. Eastern Daylight Time / 9:00 a.m. Central Daylight Time. The presentation is open to all interested parties and may include forward-looking information.

To access the call, please dial in approximately ten minutes before the start of the call.

Conference Call and Webcast Details

Date / Time: May 7, 2025 - 9:00 AM Central Time

Webcast: https://events.q4inc.com/attendee/852779315

U.S. Toll-Free Dial-In: (800) 715-9871

International Dial-In: +1 (646) 307-1963

Conference ID: 1774704

For those unable to participate in the live call, an audio replay will be available following the call through midnight Wednesday, May 14, 2025. To access the replay, please call (800) 770-2030 or +1 (609) 800-9909 (International) and enter playback ID 1774704 followed by the # key. A replay of the webcast will also be archived shortly after the call and can be accessed on the Company's website.

About Innovex International, Inc.

Innovex International, Inc (NYSE: INVX) is a Houston-based company established in 2024 following the merger of Dril-Quip, Inc and Innovex Downhole Solutions, Inc.

Our comprehensive portfolio extends throughout the lifecycle of the well, and innovative product integration ensures seamless transitions from one well phase to the next, driving efficiency, lowering cost, and reducing the rig site service footprint for the customer.

With locations throughout North America, Latin America, Europe, the Middle East and Asia, no matter where you need us, our team is readily available with technical expertise, conventional and innovative technologies, and ever-present customer service.

Forward-Looking Statements

Certain statements contained in this press release and oral statements made regarding the matters addressed in this release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside of Innovex's control, that could cause actual results to differ materially from the results discussed in the forward-looking statements.

Forward-looking statements can be identified by the use of forward-looking terminology including "may," "believe," "expect," "intend," "anticipate," "plan," "should," "estimate," "continue," "potential," "will," "hope" or other similar words and include the Company's expectation of future performance contained herein. These statements discuss future expectations, contain projections of results of operations or of financial condition, or state other "forward-looking" information, including without limitation statements regarding timing and ability to complete the sale of the Eldridge facility and the expected benefits of such sale. You are cautioned not to place undue reliance on any forward-looking statements, which can be affected by assumptions used or by risks or uncertainties. Consequently, no forward-looking statements can be guaranteed. When considering these forward-looking statements, you should keep in mind the risks related to the Company's merger and acquisition activities, including the ultimate outcome and results of integrating operations, the effects of the Company's merger and acquisition activities (including the Company's future financial condition, results of operations, strategy and plans), potential adverse reactions or changes to business relationships resulting from the completion of mergers and acquisitions, expected benefits from mergers and acquisition and the ability of the Company to realize those benefits, the significant costs required to integrate operations, whether merger or acquisition-related litigation will occur and, if so, the results of any litigation, settlements and investigations, operating hazards, natural disasters, weather-related delays, casualty losses and other matters beyond our control; acts of terrorism, war or political or civil unrest in the United States or elsewhere; loss or corruption of our information or a cyberattack on our computer systems; the risks related to economic conditions and other factors noted in the Company's Annual Report on Form 10-K, any Quarterly Reports on Form 10-Q and the other documents that the Company files with the Securities and Exchange Commission. The risk factors and other factors noted therein could cause actual results to differ materially from those contained in any forward-looking statement. Innovex disclaims any duty to update and does not intend to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this press release, except as may be required by law.

 
                 Innovex International, Inc. 
     Condensed Consolidated Statements of Operations and 
                     Comprehensive Income 
      (in thousands, except share and per share amounts) 
                         (Unaudited) 
 
                               Three Months Ended 
                   ------------------------------------------ 
                    March 31,    December 31,    March 31, 
                       2025          2024           2024 
                   ------------  ------------  -------------- 
 Revenues          $   240,415   $   250,687   $   127,997 
 
 Cost of revenues      163,911       165,817        78,907 
 Selling, general 
  and 
  administrative 
  expenses              32,349        38,278        21,337 
 (Gain) loss on 
  sale of assets           148          (167)         (124) 
 Depreciation and 
  amortization          14,945        12,039         4,793 
 Impairment of 
  long-lived 
  assets                 2,924             -             - 
 Acquisition and 
  integration 
  costs                  4,288         7,808           773 
 ----------------   ----------    ----------    ---------- 
     Income from 
      operations   $    21,850   $    26,912   $    22,311 
 
 Interest expense          700           375           719 
 Other expense 
  (income), net           (214)          700           520 
 Equity method 
  earnings                   -          (386)         (468) 
 Reduction of 
  bargain 
  purchase                   -         6,847             - 
 Gain on 
  consolidation 
  of equity 
  method 
  investment                 -        (8,037)            - 
 ----------------   ----------    ----------    ---------- 
     Income 
      before 
      income 
      taxes        $    21,364   $    27,413   $    21,540 
 
 Income tax 
  expense 
  (benefit)              6,607        (4,376)        5,123 
 ----------------   ----------    ----------    ---------- 
 Net income        $    14,757   $    31,789   $    16,417 
 ================   ==========    ==========    ========== 
 Foreign currency 
  translation 
  adjustment             4,616       (10,607)        1,030 
 ----------------   ----------    ----------    ---------- 
 Comprehensive 
  income           $    19,373   $    21,182   $    17,447 
 ================   ==========    ==========    ========== 
 
 Earnings per 
  common share 
     Basic         $      0.21   $      0.47   $      0.53 
     Diluted       $      0.21   $      0.47   $      0.51 
 Weighted average 
  common shares 
  outstanding 
     Basic          69,290,100    67,889,524    30,978,328 
     Diluted        69,477,519    68,044,174    32,292,887 
 
 
 
                     Innovex International, Inc. 
                Condensed Consolidated Balance Sheets 
                           (in thousands) 
                             (Unaudited) 
 
                             March 31,    December 31,    March 31, 
                                2025          2024           2024 
                             ----------  --------------  ----------- 
 Assets 
 Current assets 
     Cash and cash 
      equivalents            $   68,116   $      73,278   $    7,635 
     Trade receivable, net      236,020         239,506      121,339 
     Inventories, net           269,251         271,173      144,466 
     Other current assets        59,251          57,434       20,992 
 --------------------------   ---------      ----------      ------- 
         Total current 
          assets                632,638         641,391      294,432 
 
 Noncurrent assets 
     Property and 
      equipment, net            188,426         190,786       55,485 
     Equity method 
      investment                      -               -       19,435 
     Goodwill and net 
      intangibles               180,314         168,539       63,733 
     Right of use leases - 
      operating, net             56,960          54,873       30,895 
     Deferred tax asset, 
      net                       128,992         134,540       14,694 
     Other long-term assets       8,673           7,354        2,140 
 --------------------------   ---------      ----------      ------- 
         Total noncurrent 
          assets                563,365         556,092      186,382 
 
         Total assets        $1,196,003   $   1,197,483   $  480,814 
 ==========================   =========      ==========      ======= 
 
 Liabilities and 
  stockholders' equity 
 Current liabilities 
     Accounts payable        $   76,391   $      65,201   $   36,149 
     Accrued expenses            37,116          60,593       23,853 
     Operating lease 
      liabilities                11,535          10,547        7,162 
     Other current 
      liabilities                15,221          15,850          552 
     Current portion of 
      long-term debt and 
      finance lease 
      obligations                 5,556          10,467       10,482 
 --------------------------   ---------      ----------      ------- 
         Total current 
          liabilities           145,819         162,658       78,198 
 
 Noncurrent liabilities 
     Long-term debt and 
      finance lease 
      obligations                19,679          24,901       32,760 
     Operating lease 
      liabilities                45,962          45,153       25,522 
     Other long-term 
      liabilities                 6,167           6,615           29 
 --------------------------   ---------      ----------      ------- 
         Total noncurrent 
          liabilities            71,808          76,669       58,311 
 --------------------------   ---------      ----------      ------- 
         Total Liabilities   $  217,627   $     239,327   $  136,509 
 
         Total 
          stockholders' 
          equity             $  978,376   $     958,156   $  344,305 
 
         Total liabilities 
          and stockholders' 
          equity             $1,196,003   $   1,197,483   $  480,814 
 ==========================   =========      ==========      ======= 
 
 
 
                  Innovex International, Inc. 
        Condensed Consolidated Statement of Cash Flows 
      (in thousands, except share and per share amounts) 
                          (Unaudited) 
 
                                  Three Months Ended 
                        -------------------------------------- 
                        March 31,   December 31,    March 31, 
                           2025         2024           2024 
                        ---------  --------------  ----------- 
 Cash flows from 
  operating 
  activities 
     Net Income         $ 14,757    $     31,789   $ 16,417 
     Adjustments to 
      reconcile net 
      income to net 
      cash provided by 
      operating 
      activities          29,045           9,782      7,567 
     Changes in 
      operating assets 
      and liabilities, 
      net of amounts 
      related to 
      acquisitions       (12,712)         (5,226)   (11,379) 
 ---------------------   -------       ---------    ------- 
         Net cash 
          provided by 
          operating 
          activities    $ 31,090    $     36,345   $ 12,605 
 
 Cash flows used in 
  investing 
  activities 
     Payments on 
      acquisitions, 
      net of cash 
      acquired          $(17,413)   $    (65,521)  $      - 
     Capital 
      expenditures        (7,056)         (7,627)    (2,422) 
     Proceeds from 
      sale of property 
      and equipment        1,003           1,194        194 
     Equity method 
     investment                -               -          - 
     Cash acquired in 
     stock based 
     business 
     combination               -               -          - 
 --------------------    -------       ---------    ------- 
         Net cash used 
          in investing 
          activities    $(23,466)   $    (71,954)  $ (2,228) 
 
 Cash flows provided 
  by financing 
  activities 
     Net Borrowings 
      (Repayments) on 
      line of credit    $  1,600    $     14,000   $ (7,200) 
     Net Repayments on 
      term loan          (11,429)         (1,249)    (1,250) 
     Payments on 
      Finance Leases      (1,630)         (1,561)    (1,336) 
     Dividend payment          -               -          - 
     Other Financing      (1,940)            (50)      (471) 
 ---------------------   -------       ---------    ------- 
         Net cash 
          provided by 
          (used in) 
          financing 
          activities    $(13,399)   $     11,140   $(10,257) 
 
 Effect of exchange 
  rate changes on cash 
  and cash 
  equivalents                613          (2,148)       109 
 
 Net change in cash 
  and cash 
  equivalents           $ (5,162)   $    (26,617)  $    229 
 ---------------------   -------       ---------    ------- 
 
 

Non-GAAP Measures

Adjusted EBITDA and Adjusted EBITDA Margin

We define Adjusted EBITDA (a non-GAAP measure) as net income before interest expense, income tax expense, depreciation and amortization, (gain)/loss on sale of assets and other expense, net, further adjusted to exclude certain items which we believe are not reflective of our ongoing performance or which are non-cash in nature. Management uses Adjusted EBITDA to assess the profitability of our business operations and to compare our operating performance to our competitors without regard to the impact of financing methods and capital structure and excluding costs that management believes do not reflect our ongoing operating performance. We track Adjusted EBITDA on an absolute dollar basis and as a percentage of revenue, which we refer to as Adjusted EBITDA Margin.

Free Cash Flow

We also utilize Free Cash Flow (a non-GAAP measure) to evaluate the cash generated by our operations and results of operations. We define Free Cash Flow as net cash provided by operating activities less capital expenditures, as presented in our Consolidated Statements of Cash Flows. Management believes Free Cash Flow is useful because it demonstrates the cash that was available in the period that was in excess of our needs to fund our capital expenditures. We track Free Cash Flow both on an absolute dollar basis and as a percentage of revenue. Free Cash Flow does not represent our residual cash flow available for discretionary expenditures, as we have non-discretionary expenditures, including, but not limited to, principal payments required under the terms of our credit facility, which are not deducted in calculating Free Cash Flow.

Return on Capital Employed (ROCE)

We utilize Return on Capital Employed ("ROCE") (a non-GAAP measure) to assess the effectiveness of our capital allocation over time and to compare our capital efficiency to our competitors. We define ROCE as Income from Operations, before acquisition and integration costs and after tax (resulting in Adjusted Income from Operations, after tax) divided by average capital employed. Capital employed is defined as the combined values of debt and stockholders' equity.

Adjusted EBITDA, Adjusted EBITDA Margin, Free Cash Flow and ROCE do not represent and should not be considered alternatives to, or more meaningful than, net income and net cash provided by operating activities, or any other measure of financial performance presented in accordance with GAAP as measures of our financial performance. Our computation of Adjusted EBITDA, Free Cash Flow and ROCE may differ from computations of similarly titled measures of other companies. For a reconciliation of these non-GAAP measures to the most directly comparable GAAP measure, see tables below.

Management has provided outlook regarding Adjusted EBITDA, which is a non-GAAP financial measure and excludes certain charges. A reconciliation of this non-GAAP financial measure to the corresponding GAAP financial measure has not been provided because guidance for the various reconciling items is not provided. The Company is unable to provide guidance for these reconciling items because they cannot determine their probable significance, as certain items are outside of the Company's control and cannot be reasonably predicted since these items could vary significantly from period to period. Accordingly, reconciliations to the corresponding GAAP financial measures are not available without unreasonable effort.

 
                    Innovex International, Inc. 
          Reconciliation of Net Income to Adjusted EBITDA 
                          (in thousands) 
                            (Unaudited) 
 
                                   Three Months Ended 
                      -------------------------------------------- 
                       March 31,      December 31,     March 31, 
                          2025            2024            2024 
                      ------------  ----------------  ------------ 
 Revenue              $240,415       $   250,687      $127,997 
 
 Net Income           $ 14,757       $    31,789      $ 16,417 
 Interest expense          700               375           719 
 Income tax expense      6,607            (4,376)        5,123 
 Depreciation and 
  amortization          14,945            12,039         4,793 
 -------------------   -------          --------       ------- 
 EBITDA               $ 37,009       $    39,827      $ 27,052 
 
 Other non-operating 
  (income) expense, 
  net (1)                 (214)              700           520 
 (Gain)/Loss on sale 
  of assets                148              (167)         (124) 
 Impairment of 
  long-lived assets      2,924                 -             - 
 Acquisition and 
  integration costs 
  (2)                    4,288             7,808           773 
 Equity Method 
  Adjustment (3)             -               661           831 
 (Gain on) reduction 
  of bargain 
  purchase                   -             6,847             - 
 Gain on 
  consolidation of 
  equity method 
  investment                 -            (8,037)            - 
 Stock based 
  compensation           1,766             1,424           468 
 IPO Preparation 
  Expenses (4)               -                 -         2,985 
 -------------------   -------          --------       ------- 
 Adjusted EBITDA      $ 45,921       $    49,063      $ 32,505 
 
 Net Income (Loss) % 
  Revenue                    6%               13%           13% 
 Adjusted EBITDA 
  Margin                    19%               20%           25% 
 
 
 
  (1) Primarily represents foreign currency exchange gain/loss, gain/loss on 
  lease terminations, and other non-operating items 
  (2) Consists of legal, accounting, advisory fees, and other integration 
  costs associated with acquisitions, primarily related to Dril-Quip, DWS and 
  SCF. These Acquisition and integration costs are one-time in nature and 
  represent expenses that we do not view as normal operating expenses 
  necessary to operate our business. 
  (3) Reflects the elimination of our percentage of interest expense, 
  depreciation, amortization and other non-recurring expenses included within 
  Equity method earnings relating to our unconsolidated investment in DWS. 
  (4) Reflects legal, consulting and accounting fees and expenses related to 
  IPO preparation. 
 
 
 
                    Innovex International, Inc. 
         Reconciliation of Income from Operations to ROCE 
                          (in thousands) 
                            (Unaudited) 
 
                                  Twelve Months Ended 
                      -------------------------------------------- 
                       March 31,      December 31,     March 31, 
                          2025            2024            2024 
                      ------------  ----------------  ------------ 
 Income from 
  operations          $ 48,614       $    49,075      $ 97,228 
 Plus: Acquisition 
  and integration 
  costs                 36,815            33,300         2,554 
 Less: Income tax 
  expense               (3,971)           (2,487)      (24,709) 
 -------------------   -------          --------       ------- 
 Adjusted income 
  from operations, 
  after tax           $ 81,458       $    79,888      $ 75,073 
 
 Beginning debt       $ 43,242       $    50,390      $ 82,799 
 Beginning equity      344,305           328,921       270,771 
 Ending debt            25,235            35,368        43,242 
 Ending equity         978,376           958,156       344,305 
 -------------------   -------          --------       ------- 
 Average capital 
  employed            $695,579       $   686,418      $370,559 
 
 ROCE                       12%               12%           20% 
 
 
 
                    Innovex International, Inc. 
   Reconciliation of Net Cash from Operations to Free Cash Flow 
                          (in thousands) 
                            (Unaudited) 
 
                                    Three Months Ended 
                        ------------------------------------------ 
                         March 31,    December 31,     March 31, 
                            2025          2024            2024 
                        -----------  --------------  ------------- 
 Net cash provided by 
  (used in) operating 
  activities             $  31,090    $     36,345    $  12,605 
 Capital expenditures    $  (7,056)   $     (7,627)   $  (2,422) 
 ---------------------      ------       ---------       ------ 
 Free Cash Flow          $  24,034    $     28,718    $  10,183 
 
 
 
                      Innovex International, Inc. 
                      Geographic Revenue Details 
                            (in thousands) 

(MORE TO FOLLOW) Dow Jones Newswires

May 06, 2025 16:30 ET (20:30 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10